Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Hawk

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Research|April 15, 2000
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryosR F Jacoby, C E Cole, K Tutsch, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Perspectives on chemoprevention agent selection and short-term clinical prevention trialsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Potential use of lipoxygenase inhibitors for cancer chemopreventionV E Steele, C A Holmes, E T Hawk, et al.
Oncology (Williston Park, N.Y.)|October 1, 1996
Strategies for identification and clinical evaluation of promising chemopreventive agentsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999
Lipoxygenase inhibitors as potential cancer chemopreventivesV E Steele, C A Holmes, E T Hawk, et al.
Progress in Clinical and Biological Research|January 1, 1997
Perspectives and progress in development of breast cancer chemopreventive drugsG J Kelloff, C W Boone, J A Crowell, et al.
Seminars in Oncology|April 1, 1997
Progress in clinical chemopreventionG J Kelloff, E T Hawk, J E Karp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Aromatase inhibitors as potential cancer chemopreventivesG J Kelloff, R A Lubet, R Lieberman, et al.
IARC Scientific Publications|January 1, 1996
Mechanistic considerations in the evaluation of chemopreventive dataG J Kelloff, C W Boone, V E Steele, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Research|April 15, 2000
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryosR F Jacoby, C E Cole, K Tutsch, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Perspectives on chemoprevention agent selection and short-term clinical prevention trialsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2000
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancerG J Kelloff, C C Sigman, K M Johnson, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Potential use of lipoxygenase inhibitors for cancer chemopreventionV E Steele, C A Holmes, E T Hawk, et al.
Oncology (Williston Park, N.Y.)|October 1, 1996
Strategies for identification and clinical evaluation of promising chemopreventive agentsG J Kelloff, E T Hawk, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 1, 1999
Lipoxygenase inhibitors as potential cancer chemopreventivesV E Steele, C A Holmes, E T Hawk, et al.
Progress in Clinical and Biological Research|January 1, 1997
Perspectives and progress in development of breast cancer chemopreventive drugsG J Kelloff, C W Boone, J A Crowell, et al.
Seminars in Oncology|April 1, 1997
Progress in clinical chemopreventionG J Kelloff, E T Hawk, J E Karp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Aromatase inhibitors as potential cancer chemopreventivesG J Kelloff, R A Lubet, R Lieberman, et al.
IARC Scientific Publications|January 1, 1996
Mechanistic considerations in the evaluation of chemopreventive dataG J Kelloff, C W Boone, V E Steele, et al.
Pageof 3